Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zoetis Inc. Director's Dealing 2021

Apr 22, 2021

29945_dirs_2021-04-22_fe69230f-5b33-49c2-b857-ab3658c63516.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zoetis Inc. (ZTS)
CIK: 0001555280
Period of Report: 2021-04-21

Reporting Person: Chen Heidi C. (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-21 Common Stock M 11637 $55.02 Acquired 36282 Direct
2021-04-21 Common Stock S 11637 $170.14 Disposed 24645 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-21 Stock Option $ M 11637 Disposed Common Stock (11637.0) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2020.

F2: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4: 11,637 options granted February 14, 2017 at an exercise price of $55.02 per option.

F5: Each option vests on the third anniversary of the date of grant.

F6: Each option expires on the tenth anniversary of the date of grant.

F7: 12,238 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 8,758 options granted February 10, 2021 at an exercise price of $160.62 per option.